drugset / Trial / NCT01783106

Antibiotics and Hydroxychloroquine in Crohn's

NCT01783106

RandomizedCrossoverOpen-labelTreatment

Summary

There is growing evidence that Crohn's disease may be caused by replication of bacteria, perhaps particularly E. coli, within macrophages (a specialized sort of white blood cell). Laboratory studies show that a combination of antibiotics that can penetrate macrophages (such as ciprofloxacin and doxycycline) together with the anti-malarial drug hydroxychloroquine (which makes the contents of macrophage vesicles more alkaline and helps them to kill intracellular bacteria) is particularly effective at killing the E. coli within macrophages.

Timeline

Start
2014-02-01
Primary completion
2019-04-18
Completion
2019-09-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Budesonide Small molecule 9 mg Oral
Subject Ciprofloxacin Small molecule 500 mg Oral
Subject Doxycycline Small molecule 100 mg Oral
Subject Hydroxychloroquine Small molecule 200 mg Oral

Indications